Viral pneumonia as a serious complication of etanercept therapy [2]

Annals of Internal Medicine

Volumn 136, Issue 2, 2002, Pages 174-

  Smith, Davey ^a   Letendre, Scott ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LETTER; PARAINFLUENZA VIRUS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; THORAX RADIOGRAPHY; UPPER RESPIRATORY TRACT INFECTION; VIRUS PNEUMONIA;

EID: 0037080063     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-136-2-200201150-00020     Document Type: Letter

References (5)

1. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
2. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial
3. Increased tumor necrosis factor-alpha (TNF-alpha) gene expression in parainfluenza type 1 (Sendai) virus-induced bronchiolar fibrosis
4. Etanercept in the treatment of psoriatic arthritis and psoriasis: A randomised trial
5. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate